Dr. Zarrabi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1025 Walnut Street
Philadelphia, PA 19107
Education & Training
Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2018 - 2021
Stony Brook Medicine/University HospitalChief Residency, Internal Medicine, 2018 - 2019- Stony Brook Medicine/University HospitalResidency, Internal Medicine, 2015 - 2018
St. George's University School of MedicineClass of 2015
Certifications & Licensure
NJ State Medical License 2023 - 2025
PA State Medical License 2019 - 2024
NY State Medical License 2018 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 144 citationsInhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration.Kevin Zarrabi, Antoine Dufour, Jian Li, Cem Kuscu, Ashleigh Pulkoski-Gross
The Journal of Biological Chemistry. 2011-09-23 - 2 citationsPredictive and Prognostic Biomarkers and Tumor Antigens for Targeted Therapy in Urothelial Carcinoma.Aditya Eturi, Amman Bhasin, Kevin K Zarrabi, William J Tester
Molecules. 2024-04-22 - 71 citationsNew treatment options for metastatic renal cell carcinoma with prior anti-angiogenesis therapyKevin Zarrabi, Chunhui Fang, Shenhong Wu
Journal of Hematology & Oncology. 2017-02-02
Press Mentions
Dr. Kevin Zarrabi Talks Treatment of Metastatic Renal Cell CarcinomaJuly 12th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
